Free Trial
NYSEARCA:KURE

KraneShares MSCI All China Health Care Index ETF (KURE) Price, Holdings, & News

$16.72 -0.14 (-0.83%)
As of 06/18/2025 04:10 PM Eastern

About KraneShares MSCI All China Health Care Index ETF (NYSEARCA:KURE)

Key Stats

Today's Range
$16.59
$16.87
50-Day Range
$14.74
$17.98
52-Week Range
$12.91
$20.51
Volume
14,415 shs
Average Volume
44,372 shs
Market Capitalization
$88.62 million
Assets Under Management
$89.76 million
Dividend Yield
1.08%
Net Expense Ratio
0.65%
Aggregate Rating
Moderate Buy

ETF Overview

The KraneShares MSCI All China Health Care Index ETF (KURE) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index of large- and mid-cap Chinese stocks in the health care sector. KURE was launched on Feb 1, 2018 and is managed by KraneShares.

KraneShares MSCI All China Health Care Index ETF Expenses

TypeKUREHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.78%0.56%0.56%0.51%0.53%
Other Expenses0.01%0.47%0.57%0.60%0.56%
Total Expense0.79%0.75%0.76%0.74%0.73%
Fee Waiver-0.14%-0.67%-0.67%-0.72%-0.63%
Net Expense0.65%0.60%0.63%0.58%0.60%
Receive KURE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for KraneShares MSCI All China Health Care Index ETF and its competitors with MarketBeat's FREE daily newsletter.

KURE ETF News Headlines

Make 22x more from this summer’s Bitcoin boom
Bitcoin is on fire again. Wall Street’s piling in. ETFs are smashing volume records. And regular investors are finally starting to believe. But here’s the twist: Some of the biggest profits aren’t going to the people who hold Bitcoin. They’re going to those who “skim” it. Bitcoin Skimming has already CRUSHED Bitcoin’s returns.
KURE KraneShares MSCI All China Health Care Index ETF
See More Headlines

KURE ETF - Frequently Asked Questions

KraneShares MSCI All China Health Care Index ETF's stock was trading at $14.19 on January 1st, 2025. Since then, KURE stock has increased by 17.8% and is now trading at $16.72.
View the best growth stocks for 2025 here
.

Top institutional shareholders of KraneShares MSCI All China Health Care Index ETF include OLD Mission Capital LLC (3.65%) and Jane Street Group LLC (1.27%).

Shares of KURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that KraneShares MSCI All China Health Care Index ETF investors own include Alibaba Group (BABA), NVIDIA (NVDA), Meta Platforms (META), PayPal (PYPL), Visa (V), Micron Technology (MU) and Tesla (TSLA).

Fund Details

Issuer
KraneShares
Fund Name
KraneShares MSCI All China Health Care Index ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:KURE
Inception Date
1/31/2018
Fund Manager
Mark Schlarbaum
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
MSCI China All Shares Health Care 10/40 Index
Category
Sector
Focus
Health Care
Development Level
Emerging Markets
Region
Asia-Pacific
Number of Holdings
55

Fund Statistics

Assets Under Management
$89.76 million
Average Daily Volume
$41.29 thousand
Discount/Premium
-0.06%

Administrator, Advisor and Custodian

Administrator
SEI Investments Global Funds Services
Advisor
Krane Funds Advisors, LLC
Custodian
Brown Brothers Harriman & Co.
Distributor
SEI Investments Distribution Co.
Transfer Agent
Brown Brothers Harriman & Co.
Trustee
N/A
Lead Market Maker
GTS

Options

Optionable
N/A
Short Interest
35,600 shs

Miscellaneous

Beta
0.20
Creation Unit
50,000
Creation Fee
$1,320.00
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Top 10 KURE Holdings

  • BEIGENE LTD
    Holding Weight: 9.19%
  • Jiangsu Hengrui Medicine Co., Ltd.
    Holding Weight: 7.75%
  • WuXi Biologics (Cayman) Inc.
    Holding Weight: 6.43%
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    Holding Weight: 6.24%
  • CSPC Pharmaceutical Group Limited
    Holding Weight: 4.85%
  • Innovent Biologics, Inc.
    Holding Weight: 4.63%
  • Akeso, Inc.
    Holding Weight: 4.24%
  • Sino Biopharmaceutical Limited
    Holding Weight: 4.16%
  • WuXi AppTec Co., Ltd.
    Holding Weight: 3.12%
  • Zhangzhou Pientzehuang Pharmaceutical., Ltd
    Holding Weight: 2.82%

KURE Sector Exposure

KURE Industry Exposure


This page (NYSEARCA:KURE) was last updated on 6/20/2025 by MarketBeat.com Staff
From Our Partners